BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 25819405)

  • 1. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources.
    Radtke S; Haworth KG; Kiem HP
    Exp Hematol; 2016 Jun; 44(6):502-7. PubMed ID: 27016273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.
    Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA
    Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow.
    Kinniburgh D; Russell NH
    Bone Marrow Transplant; 1993 Nov; 12(5):489-94. PubMed ID: 7507766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R; Tjønnfjord GE; Egeland T
    J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources.
    Tura O; Barclay GR; Roddie H; Davies J; Turner ML
    J Transl Med; 2007 Jul; 5():37. PubMed ID: 17640360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.
    da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM
    J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.